Written by Klarity Editorial Team
Published: Aug 15, 2026

Last updated: August 15, 2026
Phentermine for weight loss is a short-term prescription option, not an over-the-counter diet pill. Clinicians may discuss it when BMI and health history support medical treatment and lifestyle change alone has not been enough. It is a Schedule IV controlled medicine. A licensed clinician still has to decide whether it is appropriate for you.
Want medical weight management support? Klarity Health connects you with over 2,000 licensed providers who can review your history and discuss whether a prescription plan fits. Coverage varies by insurance plan. See if you may qualify → · Browse health conditions · Online prescriptions
Phentermine hydrochloride is a sympathomimetic amine anorectic. In plain language, it is a stimulant-class appetite suppressant. DailyMed lists it as a short-term adjunct in a weight-reduction plan based on exercise, behavior change, and calorie restriction ([DailyMed](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e6ea6906-c4c9-4d59-9816-d2ffb1f042de)).
Common tablet and capsule strengths include 37.5 mg. Some products (such as Lomaira) use a lower strength for split dosing. Brand names you may see include Adipex-P. Generic phentermine is widely used. A clinician chooses the product and dose. Do not buy unlabeled “phentermine” capsules from social ads or overseas sites.
Phentermine is not the same as a store-shelf over the counter appetite suppressant. It requires a prescription. For the wider oral-option map, see our guides on appetite suppressant pills and prescription weight loss medication online.
NIDDK describes when a clinician may consider a weight-management medicine: adult BMI of 30 or greater, or BMI of 27 or greater plus a weight-related problem such as high blood pressure or type 2 diabetes ([NIDDK](https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity)). DailyMed uses the same BMI thresholds for phentermine ([DailyMed](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e6ea6906-c4c9-4d59-9816-d2ffb1f042de)).
Mayo Clinic repeats those BMI cutoffs for prescription weight-loss drugs as a class and notes that these medicines are not for people who are pregnant, breastfeeding, or trying to become pregnant ([Mayo Clinic](https://www.mayoclinic.org/healthy-lifestyle/weight-loss/in-depth/weight-loss-drugs/art-20044832)).
A high BMI alone does not guarantee a prescription. Heart history, blood pressure, other stimulants, MAOI use, glaucoma, hyperthyroidism, substance-use history, and pregnancy plans all matter. The clinician may decline phentermine and discuss a different class, such as Contrave or orlistat.
Phentermine acts on the central nervous system and reduces appetite. NIDDK groups several older appetite medicines, including phentermine, as short-term options that curb hunger ([NIDDK](https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity)). It does not block fat absorption the way orlistat does, and it is not a GLP-1 weekly injection.
An NCBI clinical review of pharmacologic treatment for adult overweight and obesity reports that phentermine and related noradrenergic agents can produce greater short-term weight loss than placebo when people also change diet. One cited comparison showed about 9.8% weight loss at 6 months versus 3.2% with placebo ([NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK279038/)). Individual results vary. Lifestyle change remains the base of care.
Mayo Clinic notes that a 5% to 10% loss of body weight can improve blood pressure, blood sugar, and triglycerides, and that prescription drugs plus lifestyle change outperform lifestyle change alone ([Mayo Clinic](https://www.mayoclinic.org/healthy-lifestyle/weight-loss/in-depth/weight-loss-drugs/art-20044832)).
The FDA label calls phentermine a short-term adjunct for a few weeks ([DailyMed](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e6ea6906-c4c9-4d59-9816-d2ffb1f042de)). NIDDK states that some appetite medicines such as phentermine are approved only for a few weeks, and that longer off-label use has limited research ([NIDDK](https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity)).
Mayo Clinic’s 2026 overview lists phentermine alone among four short-term agents and describes short-term use as less than 12 months in that article. Qsymia (phentermine-topiramate) sits on the long-term list instead ([Mayo Clinic](https://www.mayoclinic.org/healthy-lifestyle/weight-loss/in-depth/weight-loss-drugs/art-20044832)).
If weight loss stalls or side effects appear, the clinician may stop the drug or switch classes. Mayo Clinic suggests a different plan if a person has not lost at least 5% of body weight after 3 to 6 months on a full dose of a longer-term agent. That checkpoint is a clinical habit, not a guarantee for phentermine specifically ([Mayo Clinic](https://www.mayoclinic.org/healthy-lifestyle/weight-loss/in-depth/weight-loss-drugs/art-20044832)).
Stimulant-class effects are common: faster heart rate, higher blood pressure, trouble sleeping, dry mouth, restlessness, and constipation. Mayo Clinic lists faster heart rate, higher blood pressure, insomnia, constipation, and nervousness among phentermine-related effects ([Mayo Clinic](https://www.mayoclinic.org/healthy-lifestyle/weight-loss/in-depth/weight-loss-drugs/art-20044832)). NCBI notes that phentermine and diethylpropion side effects relate to their stimulant action ([NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK279038/)).
DailyMed contraindications include history of cardiovascular disease, hyperthyroidism, glaucoma, agitated states, history of drug abuse, pregnancy, nursing, and use of MAO inhibitors within 14 days ([DailyMed](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e6ea6906-c4c9-4d59-9816-d2ffb1f042de)). Tell the clinician about every stimulant, antidepressant, and blood-pressure medicine you take.
Seek urgent care for chest pain, severe headache, fainting, shortness of breath, or thoughts of self-harm. This article is education, not a diagnosis.
Qsymia combines phentermine with topiramate and is FDA-approved for chronic weight management in adults and in some adolescents. Topiramate raises the risk of birth defects, so pregnancy prevention is part of that product’s counseling ([Mayo Clinic](https://www.mayoclinic.org/healthy-lifestyle/weight-loss/in-depth/weight-loss-drugs/art-20044832); [NIDDK](https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity)).
Other FDA-approved long-term options Mayo Clinic lists include Contrave, Saxenda, Xenical, Wegovy, and Zepbound. Orlistat is also available in a lower-dose nonprescription form (Alli). Insurance coverage for GLP-1s and other brands often varies by plan and may require prior authorization. Cigna/ESI did not remove Zepbound in the same way some other PBMs did; Aetna/CVS Caremark reinstated Zepbound October 1, 2026. Your card still controls your copay.
Lifestyle change stays first-line even when a medicine is added ([NIDDK](https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity)).
Phentermine is Schedule IV. A legitimate online path is a real-time visit with a clinician licensed in your state, not a quiz that mails pills. Federal telemedicine flexibilities for controlled medicines currently run through December 31, 2026, if DEA registration and other conditions are met ([Telehealth.HHS.gov](https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth)). State law, PDMP checks, and pharmacy policy still apply. Some states require electronic prescribing for Schedule IV drugs.
Klarity Health maintains a medication page for phentermine online. That page is product-specific. This article covers the clinical and safety context around phentermine weight loss care.
Coverage varies by insurance plan. A visit claim and a pharmacy claim can have different rules. Ask your plan whether phentermine 37.5 is on formulary and whether a prior authorization is required.
Klarity Health connects adults with more than 2,000 licensed providers. A typical weight-management visit covers history, medications, BMI and related conditions, and whether a short-term agent, a longer-term oral option, or a different path is safer. The clinician may not prescribe phentermine. That is a safety decision, not a sales step.
If a prescription is appropriate, the pharmacy you choose fills it. Follow-up matters because blood pressure, sleep, and mood can change on a stimulant. Related care includes online weight loss treatment, online prescriptions, and support for anxiety or depression when those conditions are part of the picture.
See if you may qualify for a weight-management visit →
No. Qsymia is phentermine plus topiramate and is approved for longer-term use. Phentermine alone is labeled for short-term use ([Mayo Clinic](https://www.mayoclinic.org/healthy-lifestyle/weight-loss/in-depth/weight-loss-drugs/art-20044832)).
No legitimate U.S. pharmacy should fill it without a valid prescription from a licensed clinician. Avoid websites that skip an evaluation.
Sometimes. Many plans treat it as a pharmacy benefit with a copay. Some exclude weight-loss drugs. Coverage varies by plan. Verify benefits before you book.
It is a common strength of phentermine hydrochloride. Dose timing and whether you take it daily or in split doses is a clinician decision.
Disclaimer: This article is for education. It is not medical advice and does not confirm that any insurance plan will pay for a visit or a medicine. Coverage varies by plan. Confirm benefits and talk with a licensed clinician about your own risks before you start treatment. Klarity Health has 2,000+ licensed providers. Availability depends on your state and clinical fit.
Find the right provider for your needs — select your state to find expert care near you.